Researchers at the KU Leuven and University of Antwerp contributed to a large international team studying ferroptosis inhibition as a therapeutic strategy against ischemia-reperfusion injury in transplantation and related conditions. Our contribution in this work, which was published in the prestigious journal Cell resulted in panel H of Figure 2 — a small but significant part of the study, however representing more than six months of umbrella sampling calculations performed on the European supercomputer LUMI.